BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 16706821)

  • 1. Role of Helicobacter pylori virulence factor and genotypes in non-ulcer dyspepsia.
    Tan HJ; Rizal AM; Rosmadi MY; Goh KL
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):110-5. PubMed ID: 16706821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA, babA2 genotypes and correlation with clinical outcome in Turkish patients with dyspepsia.
    Erzin Y; Koksal V; Altun S; Dobrucali A; Aslan M; Erdamar S; Dirican A; Kocazeybek B
    Helicobacter; 2006 Dec; 11(6):574-80. PubMed ID: 17083380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of Helicobacter pylori cagA, cagE and vacA in different ethnic groups in Kuala Lumpur, Malaysia.
    Tan HJ; Rizal AM; Rosmadi MY; Goh KL
    J Gastroenterol Hepatol; 2005 Apr; 20(4):589-94. PubMed ID: 15836708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study.
    Gisbert JP; Cruzado AI; Garcia-Gravalos R; Pajares JM
    Hepatogastroenterology; 2004; 51(55):303-8. PubMed ID: 15011890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
    Koskenpato J; Farkkilä M; Sipponen P
    Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
    Bojarski C; Epple HJ; Kirstein FW; Fromm M; Bisson S; Riecken EO; Schulzke JD
    Z Gastroenterol; 2000 Mar; 38(3):211-9. PubMed ID: 10768243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
    Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.
    Blum AL; Talley NJ; O'Moráin C; van Zanten SV; Labenz J; Stolte M; Louw JA; Stubberöd A; Theodórs A; Sundin M; Bolling-Sternevald E; Junghard O
    N Engl J Med; 1998 Dec; 339(26):1875-81. PubMed ID: 9862942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.
    Talley NJ; Vakil N; Ballard ED; Fennerty MB
    N Engl J Med; 1999 Oct; 341(15):1106-11. PubMed ID: 10511608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominant cagA/vacA genotypes and coinfection frequency of H. pylori in peptic ulcer or chronic gastritis patients in Zhejiang Province and correlations among different genotypes, coinfection and severity of the diseases.
    Chen XJ; Yan J; Shen YF
    Chin Med J (Engl); 2005 Mar; 118(6):460-7. PubMed ID: 15788126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular detection of Helicobacter pylori vacA and cagA genes in gastric tissue specimens of patients with peptic ulcer disease and non-ulcer dyspepsia].
    Karaman M; Abacıoğlu H; Topalak OS; Simşek I
    Mikrobiyol Bul; 2011 Jan; 45(1):11-20. PubMed ID: 21341154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia.
    Froehlich F; Gonvers JJ; Wietlisbach V; Burnand B; Hildebrand P; Schneider C; Saraga E; Beglinger C; Vader JP;
    Am J Gastroenterol; 2001 Aug; 96(8):2329-36. PubMed ID: 11513170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of virulent Helicobacter pylori strains in symptomatic Bulgarian patients.
    Boyanova L; Markovska R; Yordanov D; Marina M; Ivanova K; Panayotov S; Gergova G; Mitov I
    Diagn Microbiol Infect Dis; 2009 Aug; 64(4):374-80. PubMed ID: 19631090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA and babA2 genotypes in Thai dyspeptic patients.
    Chomvarin C; Namwat W; Chaicumpar K; Mairiang P; Sangchan A; Sripa B; Tor-Udom S; Vilaichone RK
    Int J Infect Dis; 2008 Jan; 12(1):30-6. PubMed ID: 17548220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA typing for Helicobacter pylori isolates from eradication-failed patients: comparison of the isolates before and after therapy.
    Nada T; Ando T; Nobata K; Tsuzuki T; Minami M; Ina K; Iinuma Y; Ichiyama S; Ohta M; El-Omar E; Kusugami K; Goto H
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():39-47. PubMed ID: 15298604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No correlation of babA2 with vacA and cagA genotypes of Helicobacter pylori and grading of gastritis from peptic ulcer disease patients in Brazil.
    Mattar R; dos Santos AF; Eisig JN; Rodrigues TN; Silva FM; Lupinacci RM; Iriya K; Carrilho FJ
    Helicobacter; 2005 Dec; 10(6):601-8. PubMed ID: 16302986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
    Koskenpato J; Färkkilä M; Sipponen P
    Scand J Gastroenterol; 2002 Jul; 37(7):778-84. PubMed ID: 12190090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.
    McColl K; Murray L; El-Omar E; Dickson A; El-Nujumi A; Wirz A; Kelman A; Penny C; Knill-Jones R; Hilditch T
    N Engl J Med; 1998 Dec; 339(26):1869-74. PubMed ID: 9862941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of Helicobacter pylori-induced gastritis and the effect of H. pylori eradication in patients with chronic idiopathic thrombocytopenic purpura.
    Ando T; Tsuzuki T; Mizuno T; Minami M; Ina K; Kusugami K; Takamatsu J; Adachi K; El-Omar E; Ohta M; Goto H
    Helicobacter; 2004 Oct; 9(5):443-52. PubMed ID: 15361084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.